The Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one...

|By:, SA News Editor

The Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one being that the U.S. launch of Arena Pharmaceuticals' (ARNA) and Eisai's weight-loss pill Belviq "will be a major disappointment." Feuerstein also reckons that Belviq will fail to receive European approval.